Publicacións nas que colabora con Manuel Mateo Pérez Encinas (9)

2024

  1. Integrating AIPSS-MF and molecular predictors: A comparative analysis of prognostic models for myelofibrosis

    HemaSphere

  2. Refining risk prediction in pediatric acute lymphoblastic leukemia through DNA methylation profiling

    Clinical Epigenetics, Vol. 16, Núm. 1

  3. Validation of the Artificial Intelligence Prognostic Scoring System for Myelodysplastic Syndromes in chronic myelomonocytic leukaemia: A novel approach for improved risk stratification

    British Journal of Haematology, Vol. 204, Núm. 4, pp. 1529-1535

2023

  1. CNL and aCML should be considered as a single entity based on molecular profiles and outcomes

    Blood Advances, Vol. 7, Núm. 9, pp. 1672-1681

  2. Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis

    HemaSphere, Vol. 7, Núm. 1, pp. E818

2021

  1. The risk of thrombosis in essential thrombocythemia is associated with the type of CALR mutation: A multicentre collaborative study

    European Journal of Haematology, Vol. 106, Núm. 3, pp. 371-379

2019

  1. The association of germline variants with chronic lymphocytic leukemia outcome suggests the implication of novel genes and pathways in clinical evolution

    BMC Cancer, Vol. 19, Núm. 1

2011

  1. LIF, a novel STAT5-regulated gene, is aberrantly expressed in myeloproliferative neoplasms

    Genes and Cancer, Vol. 2, Núm. 5, pp. 593-596

2009

  1. Anagrelide treatment in early pregnancy in a patient with JAK2V617F-positive essential thrombocythemia: Case report and literature review

    Acta Haematologica, Vol. 122, Núm. 4, pp. 221-222